Grab Group CEO Anthony Tan Honored as Top Winner at 41st Singapore Business Awards Institutional Investment Activity May Signal Confidence in F5 Networks UK Spy Chief Warns of Moment of Consequence as Russia and China Threats Mount PreMarket News Roundup Key Themes and Market Context Solstice Surpasses 400M TVL as NYSEListed Bullish Becomes Institutional Allocator Asbestos Discovery in UK Toys Exposes Regulatory Gaps Raising Supply Chain and Liability Concerns OCS Q1 2026 Earnings EPS Misses Estimates as Operating Losses Widen RFIL Q1 2026 Earnings Strong EPS Beat of 96 Surprises Analysts BancFirst Corporation BANF Q1 2026 Earnings Solid EPS Beat Amid Steady Operating Performance FENC Q1 2026 Earnings Unexpected Profitability Surprises Market Stock Edges Lower GPRO Q1 2026 Earnings Massive EPS Miss Despite Stock Rally PURR Q1 2026 Earnings Strong EPS Beat Overshadowed by Revenue Uncertainty MiniMed Group Inc MMED Slips 282 as Shares Approach Key Support Threshold Pegasystems PEGA Edges Higher as Shares Hold Above Key Support Space Asset Acquisition Corp SAAQ Holds Steady Near 1033 as Trading Volume Remains Subdued Rani Therapeutics RANI Plunges Nearly 10 as Stock Tests Critical Support Level Southside Bancshares SBSI Shows Modest Gains as Stock Hovers Near Key Support Levels Europes AI Trade Dependency Could Pose Strategic Risks Report Warns NEGG Q4 2022 Earnings Sharp EPS Miss Overshadows Modest Stock Uptick Apartment Investment and Management Company AIV Edges Higher as Key Support Holds CaliberCos Inc CWD Q1 2026 Earnings Significant EPS Miss Amid Challenging Real Estate Market Billionaire Stanley Druckenmiller Invests 3387 Million in Caris Life Sciences During Q1 Woodward WWD Q1 2026 Earnings Strong EPS Beat Bolstered by Operational Gains Yet Shares Edge Lower NVCT Q1 2026 Earnings BetterthanExpected Loss Narrower as Company Advances Pipeline Could a New Central Banking Model Weaken Bond Market Influence on UK Politics MIR Q1 2026 Earnings EPS Surpasses Estimates Revenue Details Unavailable Adagene Q2 2025 Earnings Clinical Progress Overshadows EPS Miss Shares Jump